Trial
NCT05479123
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Infantile Hemangioma
Intervention
Propranolol three times a day
Why stopped
due to lack of recruitment and follow up compliance
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-13